The Calcium Channel: Structure Function and Implications : Bayer Ag Centenary Symposium Stresa/Italy, May 11-14, 1988
bharatbook | 11/21/2009
Bayer AG (Bayer) is the management holding company for the Bayer Group. The company carries out its operations through three business segments, namely, Bayer HealthCare, Bayer CropScience and Bayer MaterialScience. The major products offered by the company include, ethical pharmaceuticals and other healthcare products, polymers and agricultural products. During 2008, Bayer launched its new anticoagulant
The Sloman Economics News Site (Free subscription) | 11/20/2009
The National Institute for Health and Clinical Excellence (NICE) is the independent agency in the UK charged, amongst other things, with assessing the cost-effectiveness of new drugs. In a report published on 19 November 2009, NICE found that the drug sorafenib, branded as Nexavar by its manufacturer, the German pharmaceutical company, Bayer AG, was [...]
PharmaGossip (Free subscription) | 11/20/2009
Justice Department Recovers $2.4 Billion in False Claims Cases in Fiscal Year 2009; More Than $24 Billion Since 1986 FY09 Recovery is Second Largest in History WASHINGTON, Nov. 19 /PRNewswire-USNewswire/ -- The United States secured $2.4 billion in settlements and judgments in cases involving fraud against the government in the fiscal year ending Sept. 30, 2009, the Justice Department announced today....
Business Wire (Free subscription) | 11/20/2009
NEW YORK--(BUSINESS WIRE)--Wendy R. Fleishman of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP announced that Mae Walker today filed a personal injury lawsuit against Bayer Healthcare Pharmaceuticals, Inc., for severe and lasting injuries caused by Bayer’s birth control drug Yaz. Walker’s complaint charges that Yaz is a dangerous prescription drug sold...
All Africa (Free subscription) | 11/19/2009
THE legal action instituted against Bayer CropScience AG by farmers in the United States for allegedly contaminating their farms with Genetically Modified (GM) rice seeds in 2006 is a further confirmation of the validity of tests carried out on rice samples collected by the Environmental Rights Action/Friends of the Earth Nigeria (ERA/FoEN) in Nigeria and other West African countries within the same...
Fiercebiotech (Free subscription) | 11/19/2009
Bayer HealthCare and Johnson & Johnson have good news to present about their blood-thinner Xarelto--a potential blockbuster that the FDA declined to approve months ago. Results from a long-term clinical trial showed taking Xarelto led to an 82 percent lower risk that a venous blood clot would form again compared with placebo, according to a Reuters article. The Phase III EINSTEIN-extension study...
NewsInferno (Free subscription) | 11/18/2009
Three gadolinium contrast dyes – Bayer Healthcare’s Magnevist, GE Healthcare’s Omniscan, and Covidien ’s OptiMARK -carry a higher risk of nephrogenic systemic fibrosis (NSF) than other agents on the market, according to the U.S. Food & Drug Administration (FDA). Though the agency’s drug safety unit said the risk associated with the gadolinium [...]
AboutLawsuits.com (Free subscription) | 11/13/2009
U.S. District Judge David R. Herndon, who is presiding over the federal litigation for Yaz and Yasmin birth control, has appointed a group of attorneys to serve in leadership roles, and perform certain actions on behalf of all plaintiffs who have filed a Yaz lawsuit or Yasmin lawsuit against Bayer Healthcare Pharmaceuticals. In October, [...]
Fiercebiotech (Free subscription) | 11/12/2009
Bayer will be increasing its R&D spending in 2010 and enter alliances to fight diseases like TB that largely affect developing nations, according to Werner Wenning ( photo ), the German group's chairman. Speaking at the firm's Perspective on Sustainability press conference in Leverkusen, Wenning noted that Bayer's R&D expenditure is likely to rise next year from its 2009 level of €2.9...
All Africa (Free subscription) | 11/12/2009
The legal action instituted against Bayer CropScience AG by farmers in the United States for allegedly contaminating their farms with Genetically Modified (GM) rice seeds in 2006 is a further confirmation of the validity of tests carried out on rice samples collected by the Environmental Rights Action/Friends of the Earth Nigeria (ERA/FoEN) in Nigeria and other West African countries within the same...
aarkstore | 11/11/2009
Summary This Medical Device report is an essential source for key information and data relating to the global Diabetes Care Devices market. The report provides overview of key trends, regulatory information in key countries, pricing & reimbursement, drivers and restraints, future outlook, pipeline products, news, financial deals and competitive landscape and key developments in the global Diabetes
Physorg (Free subscription) | 11/06/2009
(PhysOrg.com) -- Until recently, the genetic code of canola was a mystery. Australian researcher Dr David Edwards, in collaboration with Bayer CropScience and Keygene N.V., is the first in the world to have solved the code, discovering the sequence of the canola genome.
PR News Wire (Free subscription) | 11/04/2009
BOSTON, Nov. 4 /PRNewswire/ -- Boston Millennia Partners (BMP II) is pleased to announce that its portfolio company, Athenix Corporation, has been acquired by Bayer CropScience for $400 million. This is the second BMP II portfolio company sold for a 10X return.
The Boston Business Journal (Free subscription) | 11/04/2009
Boston Millennia Partners and Polaris Venture Partners are among the investors on the receiving end of a major cash out in Bayer CropScience’s agreement to pay up to $400 million for agri-tech developer Athenix Corp.
PR News Wire (Free subscription) | 11/03/2009
EMERYVILLE, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today reported its financial results for the third quarter 2009. Global Nexavar net sales as reported by Onyx's collaborator Bayer HealthCare Pharmaceuticals, or Bayer, were $229.2 million for the third quarter 2009, a 27% increase compared to $180.9 million in the same period in 2008. Onyx and Bayer are...
The 3 latest articles published by users on Bayer AG :
bharatbook | 11/21/2009
Bayer AG (Bayer) is the management holding company for the Bayer Group. The company carries out its operations through three business segments, namely, Bayer HealthCare, Bayer CropScience and Bayer MaterialScience. The major products offered by the company include, ethical pharmaceuticals and other healthcare products, polymers and agricultural products. During 2008, Bayer launched its new anticoagulant
aarkstore | 11/11/2009
Summary This Medical Device report is an essential source for key information and data relating to the global Diabetes Care Devices market. The report provides overview of key trends, regulatory information in key countries, pricing & reimbursement, drivers and restraints, future outlook, pipeline products, news, financial deals and competitive landscape and key developments in the global Diabetes...
aarkstore | 09/07/2009
POF (Plastic Optical Fiber) Sourcebook More than Just a Directory The "POF Sourcebook" is the first complete compilation of companies, research and development centers, Universities and other organizations that have been involved in the research, development, production, and marketing of Plastic Optical Fiber components, subsystems and systems for data applications. A major void in the Plastic Optical...
Videos